Patents by Inventor Lynn Kozma

Lynn Kozma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160033536
    Abstract: The inventors have discovered sets of proteinaceous biomarkers which can be measured in biological fluid samples to diagnosis or aid in the diagnosis of Alzheimer's disease and distinguish AD samples from non-demented samples.
    Type: Application
    Filed: September 8, 2015
    Publication date: February 4, 2016
    Inventors: Cristopher McReynolds, David M. Rocke, Lynn Kozma, Anton Wyss-Coray
  • Publication number: 20120288866
    Abstract: The embodiments described herein relate to systems and methods for producing an evaporation barrier in a PCR vial. In some embodiments, beads with a particular distribution in diameters can be used to produce a barrier for reducing the evaporation of liquid PCR samples within the PCR vial. In some embodiments, the beads can be pre-filled in the PCR vial. In use, liquid samples and/or liquid reagents can be introduced in the PCR vial pre-filled with the beads, such that the beads can be driven to the surface of the liquid PCR sample through the buoyancy of the beads.
    Type: Application
    Filed: May 11, 2012
    Publication date: November 15, 2012
    Applicant: GenturaDx, Inc.
    Inventors: Lynn KOZMA, Maureen FAIRCHILD, Jesus CHING
  • Patent number: 8119352
    Abstract: The present invention provides methods and kits for conducting multiplex nucleic acid amplification reactions by controlling target sequence replication times. In one aspect, such control is exerted by selecting different lengths of target polynucleotides for amplification. In another aspect, control is exerted by providing sequence-specific polymerase inhibitors, such as specific blocking oligonucleotides. In accordance with the invention, multiple target polynucleotides can be sequentially amplified in an amplification reaction conducted in different stages, wherein amplification of sequences with longer replication times is permitted in one stage but precluded in other stages by modifying polymerase extension times in the course of the reaction.
    Type: Grant
    Filed: June 19, 2007
    Date of Patent: February 21, 2012
    Assignee: Cepheld
    Inventors: Lynn Kozma, David Douglas Swenson
  • Publication number: 20110202284
    Abstract: The inventors have discovered sets of proteinaceous biomarkers which can be measured in biological fluid samples to diagnosis or aid in the diagnosis of Alzheimer's disease and distinguish AD samples from non-demented samples.
    Type: Application
    Filed: February 10, 2011
    Publication date: August 18, 2011
    Inventors: Cristopher McReynolds, David M. Rocke, Lynn Kozma, Anton Wyss-Coray
  • Publication number: 20080102495
    Abstract: The present invention provides methods and kits for conducting multiplex nucleic acid amplification reactions by controlling target sequence replication times. In one aspect, such control is exerted by selecting different lengths of target polynucleotides for amplification. In another aspect, control is exerted by providing sequence-specific polymerase inhibitors, such as specific blocking oligonucleotides. In accordance with the invention, multiple target polynucleotides can be sequentially amplified in an amplification reaction conducted in different stages, wherein amplification of sequences with longer replication times is permitted in one stage but precluded in other stages by modifying polymerase extension times in the course of the reaction.
    Type: Application
    Filed: June 19, 2007
    Publication date: May 1, 2008
    Inventors: Lynn Kozma, David Swenson